Wealthcare Advisory Partners LLC Pfizer Inc Transaction History

Wealthcare Advisory Partners LLC

$3.43 Billion
Q3 2024

A detailed history of Wealthcare Advisory Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 152,720 shares of PFE stock, worth $4.03 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

152,720

Previous 134,459 13.58%

Holding current value

$4.03 Million

Previous $3.76 Million 17.46%

% of portfolio

0.13%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$27.7 - $31.39 $505,829 - $573,212	18,261 Added 13.58%	152,720 $4.42 Million
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $115,968 - $135,893	4,591 Added 3.54%	134,459 $3.76 Million
Q1 2024 Apr 15, 2024	BUY	$25.89 - $29.73 $2.02 Million - $2.32 Million	77,868 Added 149.75%	129,868 $3.6 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $121,190 - $157,413	-4,638 Reduced 8.19%	52,000 $1.5 Million
Q3 2023 Oct 12, 2023	SELL	$32.09 - $37.51 $205,311 - $239,988	-6,398 Reduced 10.15%	56,638 $1.88 Million
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $164,887 - $190,771	-4,565 Reduced 6.75%	63,036 $2.31 Million
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $9,768 - $12,717	-248 Reduced 0.37%	67,601 $2.76 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $289,285 - $377,630	6,929 Added 11.37%	67,849 $3.48 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $492,431 - $601,135	11,253 Added 22.66%	60,920 $2.67 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $112,835 - $133,787	2,425 Added 5.13%	49,667 $2.6 Million
Q1 2022 Apr 15, 2022	SELL	$45.75 - $56.69 $29,234 - $36,224	-639 Reduced 1.33%	47,242 $2.45 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $30,122 - $44,651	729 Added 1.55%	47,881 $2.83 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $52,477 - $67,411	1,337 Added 2.92%	47,152 $2.03 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $28,117 - $31,852	783 Added 1.74%	45,815 $1.79 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $148,695 - $167,698	4,440 Added 10.94%	45,032 $1.63 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $399,062 - $507,442	11,923 Added 41.59%	40,592 $1.49 Million
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $40,163 - $47,121	1,265 Added 4.62%	28,669 $1.05 Million
Q2 2020 Jul 29, 2020	BUY	$30.12 - $36.54 $24,758 - $30,035	822 Added 3.09%	27,404 $896,000
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $87,252 - $124,665	-3,228 Reduced 10.83%	26,582 $868,000
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $120,585 - $136,849	3,663 Added 14.01%	29,810 $1.17 Million
Q3 2019 Oct 17, 2019	BUY	$32.49 - $42.13 $21,021 - $27,258	647 Added 2.54%	26,147 $939,000
Q2 2019 Jul 30, 2019	BUY	$36.98 - $41.52 $6,212 - $6,975	168 Added 0.66%	25,500 $1.11 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $58,875 - $64,684	1,570 Added 6.61%	25,332 $1.08 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $47,433 - $54,079	-1,233 Reduced 4.93%	23,762 $1.04 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $25,059 - $30,395	727 Added 3.0%	24,995 $1.1 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $125,587 - $133,889	3,808 Added 18.61%	24,268 $880,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $75,626 - $87,737	-2,370 Reduced 10.38%	20,460 $726,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $157,353 - $166,956	4,731 Added 26.14%	22,830 $827,000
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $505,114 - $556,440	16,294 Added 902.71%	18,099 $646,000
Q2 2017 Aug 29, 2017	BUY	N/A	1,805	1,805 $61,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.

Account

Wealthcare Advisory Partners LLC Pfizer Inc Transaction History